Evidence map›Paper›PMID 32363625›Full record

ArticleMuscle & nerve2020

Myopathic changes associated with psychomotor delay and seizures caused by a novel homozygous mutation in TBCK.

Simona Saredi, Edmund S Cauley, Alessandra Ruggieri, Tyler M Spivey, Anna Ardissone, Marina Mora, Isabella Moroni, M Chiara Manzini

Open access · greenAbstract readCase Reports
In one paragraph

Article in Muscle & nerve, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. A novel mouse model of rare neurodevelopmental disorder, TBCK Syndrome.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Simona SarediNeuromuscular Disease and Immunology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.
Edmund S CauleyInstitute for Neuroscience and Department of Pharmacology and Physiology, George Washington University, Washington, DC.
Alessandra RuggieriNeuromuscular Disease and Immunology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.
Tyler M SpiveyInstitute for Neuroscience and Department of Pharmacology and Physiology, George Washington University, Washington, DC.
Anna ArdissoneDepartment of Pediatric Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Marina MoraNeuromuscular Disease and Immunology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.
Isabella MoroniDepartment of Pediatric Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
M Chiara ManziniInstitute for Neuroscience and Department of Pharmacology and Physiology, George Washington University, Washington, DC.
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITGeorge Washington University · USIstituti di Ricovero e Cura a Carattere Scientifico · ITJohnson University · US

Funding

Identification of Genetic and Molecular Pathways in Congenital Rare Disorders Affecting the Brain and MuscleR01NS109149 · NINDS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MANZINI, M. CHIARA · 2019 to 2023
$1.7M
NINDS NIH HHS R01 NS109149
6 · The paper itself

Abstract

backgroundBiallelic mutations in TBC1-domain containing kinase (TBCK) lead to hypotonia, global developmental delay with severe cognitive and motor deficits, and variable presentation of dysmorphic facial features and brain malformations. It remains unclear whether hypotonia in these individuals is purely neurogenic, or also caused by progressive muscle disease.

methodsWhole exome sequencing was performed on a family diagnosed with nonspecific myopathic changes by means of histological analysis and immunohistochemistry of muscle biopsy samples.

resultsA novel homozygous truncation in TBCK was found in two sisters diagnosed with muscle disease and severe psychomotor delay. TBCK was completely absent in these patients.

conclusionsOur findings identify a novel early truncating variant in TBCK associated with a severe presentation and add muscle disease to the variability of phenotypes associated with TBCK mutations. Inconsistent genotype/phenotype correlation could be ascribed to the multiple roles of TBCK in intracellular signaling and endolysosomal function in different tissues.

Indexed as

Loss of Function MutationAdolescentBrainBrain DiseasesChildDevelopmental DisabilitiesExome SequencingFemaleHomozygoteHumansLeukoencephalopathiesMagnetic Resonance ImagingMuscle HypotoniaMuscle, SkeletalMuscle WeaknessMuscular DiseasesProtein Serine-Threonine KinasesTBCK protein, humanencephalopathyexome sequencinghypotoniamTOR signalingmuscle diseaseTBCK

Identifiers

PMID32363625
PMCPMC7369155
OpenAlexW3022754181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.